Published in Emerg Infect Dis on October 04, 2001
West Nile virus: a reemerging global pathogen. Emerg Infect Dis (2001) 3.27
Epitope-blocking enzyme-linked immunosorbent assays for the detection of serum antibodies to west nile virus in multiple avian species. J Clin Microbiol (2003) 3.05
Introduction of West Nile virus in the Middle East by migrating white storks. Emerg Infect Dis (2002) 2.63
Epitope-blocking enzyme-linked immunosorbent assays for detection of west nile virus antibodies in domestic mammals. J Clin Microbiol (2003) 2.31
CD8+ T cells require perforin to clear West Nile virus from infected neurons. J Virol (2006) 2.31
Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas. J Virol (2010) 1.88
Changing patterns of West Nile virus transmission: altered vector competence and host susceptibility. Vet Res (2009) 1.59
DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus. Proc Natl Acad Sci U S A (2003) 1.37
Putative new lineage of west nile virus, Spain. Emerg Infect Dis (2010) 1.35
Detection of West Nile virus antigen in mosquitoes and avian tissues by a monoclonal antibody-based capture enzyme immunoassay. J Clin Microbiol (2002) 1.30
Characterization of virulent West Nile virus Kunjin strain, Australia, 2011. Emerg Infect Dis (2012) 1.27
NS1 protein secretion during the acute phase of West Nile virus infection. J Virol (2005) 1.22
The global ecology and epidemiology of West Nile virus. Biomed Res Int (2015) 1.21
West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of alphavbeta3 integrin. J Virol (2008) 1.19
Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection. BMC Infect Dis (2009) 1.11
The naturally attenuated Kunjin strain of West Nile virus shows enhanced sensitivity to the host type I interferon response. J Virol (2011) 1.10
Vector-virus interactions and transmission dynamics of West Nile virus. Viruses (2013) 1.09
Molecular evolution of lineage 2 West Nile virus. J Gen Virol (2012) 1.05
Both E protein glycans adversely affect dengue virus infectivity but are beneficial for virion release. J Virol (2010) 1.05
Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug. J Antimicrob Chemother (2012) 1.00
Differential virulence and pathogenesis of West Nile viruses. Viruses (2013) 0.99
Molecular epidemiology and evolution of West Nile virus in North America. Int J Environ Res Public Health (2013) 0.99
Genetic variation of St. Louis encephalitis virus. J Gen Virol (2008) 0.98
A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice. J Virol (2012) 0.98
The changing epidemiology of Kunjin virus in Australia. Int J Environ Res Public Health (2013) 0.96
The West Nile virus-like flavivirus Koutango is highly virulent in mice due to delayed viral clearance and the induction of a poor neutralizing antibody response. J Virol (2014) 0.95
Multiple pathways to the attenuation of West Nile virus in south-east Texas in 2003. Virology (2010) 0.93
Vaccines in development against West Nile virus. Viruses (2013) 0.90
The Australian Public is Still Vulnerable to Emerging Virulent Strains of West Nile Virus. Front Public Health (2014) 0.85
A review of vaccine approaches for West Nile virus. Int J Environ Res Public Health (2013) 0.83
West nile virus: characteristics of an african virus adapting to the third millennium world. Open Virol J (2010) 0.83
Preliminary crystallographic characterization of an RNA helicase from Kunjin virus. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.81
The role of Australian mosquito species in the transmission of endemic and exotic West Nile virus strains. Int J Environ Res Public Health (2013) 0.80
Comparison of the neuropathology induced by two West Nile virus strains. PLoS One (2013) 0.80
Rapid fixation of a distinctive sequence motif in the 3' noncoding region of the clade of West Nile virus invading North America. Gene (2007) 0.79
Domain-based homology modeling and mapping of the conformational epitopes of envelope glycoprotein of west nile virus. J Mol Model (2005) 0.78
Animal viral diseases and global change: bluetongue and West Nile fever as paradigms. Front Genet (2012) 0.78
Virulence and Evolution of West Nile Virus, Australia, 1960-2012. Emerg Infect Dis (2016) 0.77
Pre-clinical development of a hydrogen peroxide-inactivated West Nile virus vaccine. Vaccine (2016) 0.75
Molecular typing of West Nile Virus, Dengue, and St. Louis encephalitis using multiplex sequencing. J Mol Diagn (2005) 0.75
West Nile and St. Louis encephalitis virus antibody seroconversion, prevalence, and persistence in naturally infected pig-tailed macaques (Macaca nemestrina). Clin Vaccine Immunol (2006) 0.75
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science (1999) 18.55
Flavivirus genome organization, expression, and replication. Annu Rev Microbiol (1990) 14.20
Phylogeny of the genus Flavivirus. J Virol (1998) 8.87
Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science (1985) 8.54
West Nile encephalitis epidemic in southeastern Romania. Lancet (1998) 7.73
Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol (1989) 7.06
Entomologic and avian investigations of an epidemic of West Nile fever in Romania in 1996, with serologic and molecular characterization of a virus isolate from mosquitoes. Am J Trop Med Hyg (1999) 4.62
Nucleotide and complete amino acid sequences of Kunjin virus: definitive gene order and characteristics of the virus-specified proteins. J Gen Virol (1988) 4.09
Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology (1987) 3.96
Identification of a Kunjin/West Nile-like flavivirus in brains of patients with New York encephalitis. Lancet (1999) 3.80
Extensive nucleotide changes and deletions within the envelope glycoprotein gene of Euro-African West Nile viruses. J Gen Virol (1997) 3.78
Conserved elements in the 3' untranslated region of flavivirus RNAs and potential cyclization sequences. J Mol Biol (1987) 3.30
Genetic analysis of West Nile New York 1999 encephalitis virus. Lancet (1999) 3.12
Primary structure of the West Nile flavivirus genome region coding for all nonstructural proteins. Virology (1986) 2.75
The 3'-nucleotides of flavivirus genomic RNA form a conserved secondary structure. Virology (1986) 2.50
Completion of Kunjin virus RNA sequence and recovery of an infectious RNA transcribed from stably cloned full-length cDNA. J Virol (1994) 2.43
Glycosylation and antigenic variation among Kunjin virus isolates. Virology (1995) 2.40
Nucleotide sequence and deduced amino acid sequence of the nonstructural proteins of dengue type 2 virus, Jamaica genotype: comparative analysis of the full-length genome. Virology (1988) 2.22
West Nile virus envelope proteins: nucleotide sequence analysis of strains differing in mouse neuroinvasiveness. J Gen Virol (1998) 2.18
The flaviviruses (group B arboviruses): a cross-neutralization study. J Gen Virol (1974) 2.18
Sequence analysis of the viral core protein and the membrane-associated proteins V1 and NV2 of the flavivirus West Nile virus and of the genome sequence for these proteins. Virology (1985) 2.07
Molecular characterization of the Japanese encephalitis serocomplex of the flavivirus genus. Virology (1996) 1.99
Identification of mosquito-borne flavivirus sequences using universal primers and reverse transcription/polymerase chain reaction. Res Virol (1994) 1.86
Loss of active neuroinvasiveness in attenuated strains of West Nile virus: pathogenicity in immunocompetent and SCID mice. Arch Virol (1994) 1.80
Sequence analysis of the membrane protein V3 of the flavivirus West Nile virus and of its gene. Virology (1985) 1.72
Analysis of structural properties which possibly are characteristic for the 3'-terminal sequence of the genome RNA of flaviviruses. J Gen Virol (1986) 1.52
Monoclonal antibodies to Kunjin and Kokobera viruses. Immunol Cell Biol (1991) 1.30
Secondary structure of the 3'-untranslated region of yellow fever virus: implications for virulence, attenuation and vaccine development. J Gen Virol (1997) 1.28
The neutralization of arboviruses. II. Neutralization in heterologous virus-serum mixtures with four group B arboviruses. Virology (1965) 1.21
Nucleotide sequence at the 3' end of Japanese encephalitis virus genomic RNA. Virology (1986) 1.18
A one-tube, one manipulation RT-PCR reaction for detection of Ross River virus. J Virol Methods (1992) 1.11
Flavivirus West Nile (Sarafend) egress at the plasma membrane. Arch Virol (1994) 1.06
Further observations on geographic variation in the antigenic character of West Nile and Japanese B viruses. Am J Epidemiol (1966) 0.96
Antigenic analysis of West Nile virus strains using monoclonal antibodies. Arch Virol (1988) 0.94
Strain analysis and epitope mapping of West Nile virus using monoclonal antibodies. Acta Virol (1998) 0.85
Kunjin virus isolates of Australia are genetically homogeneous. J Gen Virol (1989) 0.84
Genetic analysis of Kunjin virus isolates using HaeIII and TaqI restriction digests of single-stranded cDNA to virion RNA. Aust J Exp Biol Med Sci (1986) 0.82
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science (1999) 18.55
Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus. J Gen Virol (2000) 5.87
TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J (2000) 4.55
Nucleotide sequence and deduced amino acid sequence of the structural proteins of dengue type 2 virus, Jamaica genotype. Virology (1986) 4.34
Identification of a Kunjin/West Nile-like flavivirus in brains of patients with New York encephalitis. Lancet (1999) 3.80
Extensive nucleotide changes and deletions within the envelope glycoprotein gene of Euro-African West Nile viruses. J Gen Virol (1997) 3.78
Population dynamics of flaviviruses revealed by molecular phylogenies. Proc Natl Acad Sci U S A (1996) 3.69
Genetic analysis of West Nile New York 1999 encephalitis virus. Lancet (1999) 3.12
Arboviruses causing human disease in the Australasian zoogeographic region. Arch Virol (1994) 3.03
Emerging viral diseases of Southeast Asia and the Western Pacific. Emerg Infect Dis (2001) 2.91
Detection of West Nile virus sequences in cerebrospinal fluid. Lancet (2000) 2.83
Serologic evidence for the presence in Pteropus bats of a paramyxovirus related to equine morbillivirus. Emerg Infect Dis (1996) 2.83
Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. J Gen Virol (1977) 2.76
Genomic organization of Borna disease virus. Proc Natl Acad Sci U S A (1994) 2.74
Penicillin-binding proteins of penicillin-susceptible and -resistant pneumococci: immunological relatedness of altered proteins and changes in peptides carrying the beta-lactam binding site. Antimicrob Agents Chemother (1986) 2.72
Borna disease virus in brains of North American and European people with schizophrenia and bipolar disorder. Bornavirus Study Group. Lancet (1997) 2.54
First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality! Clin Microbiol Infect (2010) 2.53
Coronaviruses in bats from Mexico. J Gen Virol (2013) 2.53
Borna disease virus, a negative-strand RNA virus, transcribes in the nucleus of infected cells. Proc Natl Acad Sci U S A (1992) 2.44
Glycosylation and antigenic variation among Kunjin virus isolates. Virology (1995) 2.40
Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect (2004) 2.30
An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med J Aust (1996) 2.25
Tick-borne encephalitis. Antiviral Res (2003) 2.25
Phylogenetic relationships of flaviviruses correlate with their epidemiology, disease association and biogeography. J Gen Virol (2001) 2.19
The remarkable coding strategy of borna disease virus: a new member of the nonsegmented negative strand RNA viruses. Virology (1995) 2.17
Rarity of adverse effects after 17D yellow-fever vaccination. Lancet (2001) 2.14
Nucleotide sequences of genes encoding penicillin-binding proteins from Streptococcus pneumoniae and Streptococcus oralis with high homology to Escherichia coli penicillin-binding proteins 1a and 1b. J Bacteriol (1992) 2.11
Platelet-derived growth factor receptor association with Na(+)/H(+) exchanger regulatory factor potentiates receptor activity. Mol Cell Biol (2000) 2.11
Nipah virus: vaccination and passive protection studies in a hamster model. J Virol (2004) 2.09
Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infect Immun (1981) 2.08
Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J Virol (1999) 2.07
Immunodominant epitopes on the NS1 protein of MVE and KUN viruses serve as targets for a blocking ELISA to detect virus-specific antibodies in sentinel animal serum. J Virol Methods (1995) 2.06
The ecology and epidemiology of West Nile virus in Africa, Europe and Asia. Curr Top Microbiol Immunol (2002) 2.05
Five- to eight-year results of truncal vagotomy and pyloroplasty for duodenal ulcer. Br Med J (1972) 2.00
Molecular characterization of the Japanese encephalitis serocomplex of the flavivirus genus. Virology (1996) 1.99
Interaction of the pneumococcal amidase with lipoteichoic acid and choline. Eur J Biochem (1985) 1.97
Japanese encephalitis in north Queensland, Australia, 1998. Med J Aust (1999) 1.96
Cell-mediated immune response to influenza virus infections in mice. Infect Immun (1976) 1.90
Differences between cell membrane fusion activities of two dengue type-1 isolates reflect modifications of viral structure. Virology (1993) 1.86
Identification of mosquito-borne flavivirus sequences using universal primers and reverse transcription/polymerase chain reaction. Res Virol (1994) 1.86
Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. Virology (1991) 1.85
Complete coding sequence of the Alkhurma virus, a tick-borne flavivirus causing severe hemorrhagic fever in humans in Saudi Arabia. Biochem Biophys Res Commun (2001) 1.85
Ross River virus isolations from mosquitoes in arid regions of Western Australia: implication of vertical transmission as a means of persistence of the virus. Am J Trop Med Hyg (1993) 1.85
Secondary structure of the 3' untranslated region of flaviviruses: similarities and differences. Nucleic Acids Res (1997) 1.84
Efficient trans-complementation of the flavivirus kunjin NS5 protein but not of the NS1 protein requires its coexpression with other components of the viral replicase. J Virol (1999) 1.82
Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum. J Virol (2000) 1.81
The first epidemic of dengue hemorrhagic fever in French Guiana. Am J Trop Med Hyg (1994) 1.78
Henipaviruses: emerging paramyxoviruses associated with fruit bats. Curr Top Microbiol Immunol (2007) 1.77
Monoclonal antibodies to Sindbis virus glycoprotein E1 can neutralize, enhance infectivity, and independently inhibit haemagglutination or haemolysis. J Gen Virol (1982) 1.77
Apoptosis in the mouse central nervous system in response to infection with mouse-neurovirulent dengue viruses. J Virol (1998) 1.73
Emergence of fatal avian influenza in New England harbor seals. MBio (2012) 1.70
Sequence conservation in field and experimental isolates of Borna disease virus. J Virol (1994) 1.67
An arbovirus cline across the northern hemisphere. Virology (1995) 1.67
Nipah virus outbreak with person-to-person transmission in a district of Bangladesh, 2007. Epidemiol Infect (2010) 1.65
The ecology and epidemiology of Kunjin virus. Curr Top Microbiol Immunol (2002) 1.65
Oligomerization of NHERF-1 and NHERF-2 PDZ domains: differential regulation by association with receptor carboxyl-termini and by phosphorylation. Biochemistry (2001) 1.64
Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism. J Gen Virol (2001) 1.63
Complete sequence of two tick-borne flaviviruses isolated from Siberia and the UK: analysis and significance of the 5' and 3'-UTRs. Virus Res (1997) 1.63
Molecular epidemiology of dengue virus type 3 in Venezuela. J Gen Virol (2003) 1.61
West Nile in the Mediterranean basin: 1950-2000. Ann N Y Acad Sci (2001) 1.61
Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder. Mol Psychiatry (2012) 1.59
High genetic stability of the region coding for the structural proteins of yellow fever virus strain 17D. J Gen Virol (1987) 1.56
Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. J Gen Virol (1986) 1.55
Report of a fatal case of dengue infection with hepatitis: demonstration of dengue antigens in hepatocytes and liver apoptosis. Hum Pathol (1999) 1.54
Complications of surgical feeding jejunostomy in trauma patients. J Trauma (1999) 1.54
An infection-based model of neurodevelopmental damage. Proc Natl Acad Sci U S A (1999) 1.53
Japanese encephalitis as an emerging virus: the emergence and spread of Japanese encephalitis virus in Australasia. Curr Top Microbiol Immunol (2002) 1.53
Murray Valley encephalitis virus surveillance and control initiatives in Australia. National Arbovirus Advisory Committee of the Communicable Diseases Network Australia. Commun Dis Intell Q Rep (2001) 1.53
Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells. J Infect Dis (2000) 1.52
Isolation of temperature-sensitive mutants and the construction of a preliminary genetic map for influenza virus. J Gen Virol (1970) 1.52
Sequence similarity between Borna disease virus p40 and a duplicated domain within the paramyxovirus and rhabdovirus polymerase proteins. J Virol (1992) 1.51
The Autism Birth Cohort: a paradigm for gene-environment-timing research. Mol Psychiatry (2010) 1.51
Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies. J Gen Virol (1985) 1.50
RNA splicing in Borna disease virus, a nonsegmented, negative-strand RNA virus. J Virol (1994) 1.50
Isolation of Japanese encephalitis virus from mosquitoes (Diptera: Culicidae) collected in the Western Province of Papua New Guinea, 1997-1998. Am J Trop Med Hyg (2000) 1.48
Variability of penicillin-binding proteins from penicillin-sensitive Streptococcus pneumoniae. J Infect Dis (1991) 1.48
Molecular epidemiology of dengue type 2 virus in Venezuela: evidence for in situ virus evolution and recombination. J Gen Virol (2001) 1.48
Molecular characterization of the Borna disease agent. Virology (1990) 1.48
Antibody prophylaxis and therapy against Nipah virus infection in hamsters. J Virol (2006) 1.47
Molecular identification of adenoviruses in clinical samples by analyzing a partial hexon genomic region. J Clin Microbiol (2005) 1.47
GTPase activating specificity of RGS12 and binding specificity of an alternatively spliced PDZ (PSD-95/Dlg/ZO-1) domain. J Biol Chem (1998) 1.45